WFDC2 and ovarian benign neoplasm: As the tumor markers commonly used in clinical laboratory to diagnose OC, serum HE4 and CAl25 levels from the clinical case records revealed that they were the highest in EOC patients, followed by patients with benign ovarian tumors and healthy women (p < 0.001) (Figure 2(a,b)).